Cite
Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis
MLA
E, Csernok, et al. “Proteinase 3, Protease-Activated Receptor-2 and Interleukin-32: Linking Innate and Autoimmunity in Wegener’s Granulomatosis.” Clinical and Experimental Rheumatology, vol. 26, no. 3 Suppl 49, Oct. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8462cdb469694007131cc038e628e266&authtype=sso&custid=ns315887.
APA
E, C., J U, H., & W L, G. (2008). Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener’s granulomatosis. Clinical and Experimental Rheumatology, 26(3 Suppl 49).
Chicago
E, Csernok, Holle J U, and Gross W L. 2008. “Proteinase 3, Protease-Activated Receptor-2 and Interleukin-32: Linking Innate and Autoimmunity in Wegener’s Granulomatosis.” Clinical and Experimental Rheumatology 26 (3 Suppl 49). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8462cdb469694007131cc038e628e266&authtype=sso&custid=ns315887.